https://www.targetedonc.com/view/sotorasib-reveals-anti-tumor-efficacy-in-kras-g12c-positive-advanced-pancreatic-cancer
0
0
32 words
0
Comments
New results from the advanced pancreatic cancer cohort of the CodeBreaK 100 trial show positive efficacy and safety.
You are the first to view
Create an account or login to join the discussion